AveXis appoints chief compliance officer

AveXis, a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, has appointed Michael Johannesen to the executive management team as general counsel and chief compliance officer. He will report to President and CEO Sean Nolan.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.